Long-Term Efficacy and Tolerability of a Medium G' HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone

被引:0
|
作者
David, Michel
Braccini, Frederic
Garcia, Philippe
Loreto, Frederic
Benadiba, Laurent
Gorj, Mihai
Grand-Vincent, Anne
Mathey, Elena Rumyantseva
Deutsch, Jean-Jacques
Ehlinger, Agnes
Cartier, Hugues
Nadra, Karim [1 ]
Fanian, Ferial [1 ]
机构
[1] Labs Fill Med, Paris, France
来源
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY | 2023年 / 16卷
关键词
hyaluronic acid; dermal fillers; facial injections; anti-aging; skin rejuvenation; perioral area; HYALURONIC-ACID FILLER; LIDOCAINE;
D O I
10.2147/CCID.S395353
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Purpose: Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct topographical anomalies. The European directives require a continuous evaluation of the performance of these medical devices, particularly for CE marked products. Methods: An 18-month prospective randomized single-blind study for the efficacy and safety of ART FILLER Universal (AFU) was performed on the lips, the nasolabial folds, and the marionettes lines. The evaluations were performed on 153 subjects enrolled in this study. The efficacy, the longevity, and the safety were evaluated for the injected areas via area specific clinical scoring after a single injection with the filler and with no re-touch. Results: We showed here that filler injection induced potent improvements of volume restoration after a single injection on all the treated areas. These beneficial properties of the filler were significant 3 weeks after injection and during the whole study period. Moreover, injections of the filler were well tolerated by the subjects. The recorded adverse events are routinely seen with HA fillers for face volume corrections, and most of these local reactions resolved within 14 days. Conclusion: AFU was well tolerated and showed a continuous efficacy for at least 18 months, in exploratory analyses.
引用
收藏
页码:1795 / 1805
页数:11
相关论文
共 15 条
  • [1] Long-term efficacy and safety of a hyaluronic acid dermal filler based on Tri-Hyal technology on restoration of midface volume
    Kestemont, Philippe
    Fanian, Ferial
    Garcia, Philippe
    Grand-Vincent, Anne
    Benadiba, Laurent
    Delmar, Henry
    Bodokh, Isaac
    Brun, Patrick
    Braccini, Frederic
    Desouches, Christophe
    Paris, Jerome
    Nadra, Karim
    Salomon, Catherine
    Trevidic, Patrick
    JOURNAL OF COSMETIC DERMATOLOGY, 2023, 22 (09) : 2448 - 2456
  • [2] Long-Term Performance and Safety of a Superficial HA Filler With Tri-Hyal Technology on Different Facial Zones: Forehead, Cheeks, Crow's Feet, and Upper Lips
    Cartier, Hugues
    Deutsch, Jean-Jacques
    Braccini, Frederic
    Garcia, Philippe
    Ehlinger, Agnes
    David, Michel
    Loreto, Frederic
    Benadiba, Laurent
    Grand-Vincent, Anne
    Mathey, Elena Rumyantseva
    Nadra, Karim
    Fanian, Ferial
    JOURNAL OF COSMETIC DERMATOLOGY, 2025, 24 (01)
  • [3] Evaluation of the Performance and Tolerance of the Combination of an HA-based Filler with Tri-Hyal Technology and a Skin Biorevitalizer on Skin Aging Parameters
    Fanian, Ferial
    Philippon, Valerie
    Gorj, Mihai
    Mathey, Elena Rumyantseva
    Caillens, Maxence
    Goorochurn, Ranesha
    Curic, Shannel
    Humbert, Philippe
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 1095 - 1105
  • [4] A prospective multicenter clinical trial evaluating the efficacy and safety of a hyaluronic acid-based filler with Tri-Hyal technology in the treatment of lips and the perioral area
    Ehlinger-David, Agnes
    Gorj, Mihai
    Braccini, Frederic
    Loreto, Federico
    Grand-Vincent, Anne
    Garcia, Philippe
    Taieb, Maryna
    Benadiba, Laurent
    Catoni, Isabelle
    Mathey, Elena Rumyantseva
    Deutsch, Jean-Jacques
    Bahadoran, Philippe
    Vincent, Thibaud
    David, Michel
    Cartier, Hugues
    Nadra, Karim
    Moellhoff, Nicholas
    Fanian, Ferial
    JOURNAL OF COSMETIC DERMATOLOGY, 2023, 22 (02) : 464 - 472
  • [5] Comparative clinical study for the efficacy and safety of two different hyaluronic acid-based fillers with Tri-Hyal versus Vycross technology: A long-term prospective randomized clinical trial
    Braccini, Frederic
    Fanian, Ferial
    Garcia, Philippe
    Delmar, Henry
    Loreto, Federico
    Benadiba, Laurent
    Nadra, Karim
    Kestemont, Philippe
    JOURNAL OF COSMETIC DERMATOLOGY, 2023, 22 (02) : 473 - 485
  • [6] A long-term safety and efficacy study of trifarotene 50 μg/g cream in subjects with facial and truncal acne vulgaris
    Blume-Peytavi, Ulrike
    Tanghetti, Emil
    Kemeny, Lajos
    Draelos, Zoe
    Dirschka, Thomas
    Eichenfield, Lawrence
    Rich, Phoebe
    Graeber, Michael
    Saenz, Alessandra Alio
    Fowler, Joseph
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB157 - AB157
  • [7] A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin
    Sigg, N.
    Fouquet, J.
    Morin, D.
    Farges, D.
    Vrignaud, S.
    Martin, L.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (04): : 270 - 273
  • [8] A prospective, long-term observational study of the efficacy and safety of an hyaluronic acid (HA) filler in the correction of mild to severe mid-face volume deficits: 18 month interim analysis
    Goodman, G. J.
    Carlisle, I.
    Liew, S.
    Muzikants, P.
    Victoria
    Scamp, T.
    Halstead, M.
    Rogers, J.
    Callan, P.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2011, 52 : 3 - 3
  • [9] LONG-TERM SAFETY, EFFICACY, AND TOLERABILITY OF RECOMBINANT HUMAN HYALURONIDASE-FACILITATED SUBCUTANEOUS INFUSION OF IMMUNOGLOBULIN G IN PATIENTS AGED ≥16 YEARS WITH PRIMARY IMMUNODEFICIENCIES
    Wasserman, R. L.
    Stein, M.
    Kobrynski, L.
    Gupta, S.
    Grant, J.
    Rubinstein, A.
    Engl, W.
    McCoy, B.
    Leibl, H.
    Yel, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A103 - A103
  • [10] Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne
    Blume-Peytavi, U.
    Fowler, J.
    Kemeny, L.
    Draelos, Z.
    Cook-Bolden, F.
    Dirschka, T.
    Eichenfield, L.
    Graeber, M.
    Ahmad, F.
    Saenz, A. Alio
    Rich, P.
    Tanghetti, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (01) : 166 - 173